1. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
    Jorge A.R. Salvador et al, 2017, European Journal of Medicinal Chemistry CrossRef
  2. Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages
    Yuening Yang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  3. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells
    Xiaojing Li et al, 2018, European Journal of Pharmacology CrossRef
  4. Celastrol protects human retinal pigment epithelial cells against hydrogen peroxide mediated oxidative stress, autophagy, and apoptosis through sirtuin 3 signal pathway.
    Zhaojiang Du et al, 2019, J Cell Biochem CrossRef
  5. Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo
    Li-Na Xu et al, 2019, Front. Oncol. CrossRef
  6. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mohammad Mirza Aghazadeh Attari et al, 2019, DNA Repair CrossRef
  7. CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
    Li Q. Zhang et al, 2019, Technol Cancer Res Treat CrossRef
  8. Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis.
    Yunpeng Qi et al, 2018, Biol Pharm Bull CrossRef

  9. Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis


    Zhi Tao Jiang et al, 2020, OTT CrossRef

  10. MicroRNA-21-3p Engineered Umbilical Cord Stem Cell-Derived Exosomes Inhibit Tendon Adhesion


    Zhixiao Yao et al, 2020, JIR CrossRef
  11. Overexpression of microRNA‑21 inhibits the growth and metastasis of melanoma cells by targeting MKK3
    Meng Zhou et al, 2019, Mol Med Report CrossRef
  12. Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review
    Tian-Jia Liu et al, 2021, Front. Oncol. CrossRef
  13. Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach
    Yu Yuan et al, 2022, EPMA Journal CrossRef
  14. Celastrol upregulated ATG7 triggers autophagy via targeting Nur77 in colorectal cancer.
    Wenxin Zhang et al, 2022, Phytomedicine CrossRef
  15. An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer
    Shanying Huang et al, 2023, Arch Virol CrossRef
  16. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
    Cheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  17. Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors
    Sulieman Ibraheem Shelash Al‐Hawary et al, 2023, Cell Biochemistry & Function CrossRef
  18. SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
    Chiara Lambona et al, 2024, J. Med. Chem. CrossRef
  19. Mechanism research on microRNA‐669f‐5p/deoxycytidylate deaminase axis mediating sevoflurane‐induced cognitive dysfunction in aged mice
    Yuan‐Ping Zhong et al, 2024, Fundamemntal Clinical Pharma CrossRef
  20. The role of celastrol in inflammation and diseases
    Han Lei et al, 2025, Inflamm. Res. CrossRef